SCHEMBL4699253

SCHEMBL4699253

C/C(=C\c1ccc(F)cc1F)CNC[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 9/20 0.38
FAP Q12884 4/20 0.38
DPP8 Q6V1X1 4/20 0.38
DPP9 Q86TI2 4/20 0.38
DPP7 Q9UHL4 3/20 0.38
GPR119 Q8TDV5 1/20 0.37
ECE1 P42892 1/20 0.36
ACKR3 P25106 4/20 0.36
APP P05067 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
SLC6A2 P23975 1/20 0.33
HRH2 P25021 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4699255 1.00 DPP4 (0.38) DPP4FAPDPP8DPP9DPP7
SCHEMBL13316340 0.83 APP (0.48) ACKR3APPHTR1AADRA2ADRD2
SCHEMBL13349539 0.83 APP (0.48) ACKR3APPHTR1AADRA2ADRD2
SCHEMBL3539175 0.83 APP (0.48) ACKR3APPHTR1AADRA2ADRD2
SCHEMBL3539178 0.83 APP (0.48) ACKR3APPHTR1AADRA2ADRD2
SCHEMBL4752280 0.82 ALDH1A1 (0.39) DPP4FAPDPP8DPP9DPP7
SCHEMBL14601232 0.82 ALDH1A1 (0.39) DPP4FAPDPP8DPP9DPP7
SCHEMBL5576370 0.82 ALDH1A1 (0.39) DPP4FAPDPP8DPP9DPP7
Hydrochloric Acid SCHEMBL4752278 0.81 ALDH1A1 (0.38) DPP4GPR119
Hydrochloric Acid SCHEMBL4752275 0.81 ALDH1A1 (0.38) DPP4GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1909575-A2 SUBSTITUTED N-CINNAMYL BENZAMIDES ChemoCentryx Inc (US) 2008-04-16 EP disclosed
US-20070021484-A1 Substituted N-cinnamyl benzamides CHEMOCENTRYX, INC. (US) 2007-01-25 US disclosed
US-20070021484-A1 Substituted N-cinnamyl benzamides CHEMOCENTRYX, INC. (US) 2007-01-25 US disclosed
WO-2007002842-A2 SUBSTITUTED N-CINNAMYL BENZAMIDES CHEMOCENTRYX, INC. (US) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021484-A1 Substituted N-cinnamyl benzamides BRDT, BCCIP, NAT10 DPP4 1165/4885FAP 791/4885DPP8 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.